Comments
Loading...

Vanda Pharma

VNDANASDAQ
Logo brought to you by Benzinga Data
$4.83
0.153.21%
At close: -
$4.83
0.000.00%
After Hours: 1:00 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$18.00
Lowest Price Target1
$12.00
Consensus Price Target1
$14.33

Vanda Pharma (NASDAQ:VNDA) Stock, Analyst Ratings, Price Targets, Forecasts

Vanda Pharmaceuticals Inc has a consensus price target of $14.33 based on the ratings of 3 analysts. The high is $18 issued by HC Wainwright & Co. on December 23, 2024. The low is $12 issued by Jefferies on February 25, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co., HC Wainwright & Co., and Cantor Fitzgerald on December 23, 2024, October 31, 2024, and August 1, 2024, respectively. With an average price target of $16.33 between HC Wainwright & Co., HC Wainwright & Co., and Cantor Fitzgerald, there's an implied 238.16% upside for Vanda Pharmaceuticals Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Jul
1
Aug
1
Oct
1
Dec
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.8
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Cantor Fitzgerald
Jefferies

1calculated from analyst ratings

Analyst Ratings for Vanda Pharma

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Vanda Pharma (VNDA) stock?

A

The latest price target for Vanda Pharma (NASDAQ:VNDA) was reported by HC Wainwright & Co. on December 23, 2024. The analyst firm set a price target for $18.00 expecting VNDA to rise to within 12 months (a possible 272.67% upside). 4 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Vanda Pharma (VNDA)?

A

The latest analyst rating for Vanda Pharma (NASDAQ:VNDA) was provided by HC Wainwright & Co., and Vanda Pharma reiterated their buy rating.

Q

When was the last upgrade for Vanda Pharma (VNDA)?

A

There is no last upgrade for Vanda Pharma

Q

When was the last downgrade for Vanda Pharma (VNDA)?

A

The last downgrade for Vanda Pharmaceuticals Inc happened on February 25, 2022 when Jefferies changed their price target from $24 to $12 for Vanda Pharmaceuticals Inc.

Q

When is the next analyst rating going to be posted or updated for Vanda Pharma (VNDA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vanda Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vanda Pharma was filed on December 23, 2024 so you should expect the next rating to be made available sometime around December 23, 2025.

Q

Is the Analyst Rating Vanda Pharma (VNDA) correct?

A

While ratings are subjective and will change, the latest Vanda Pharma (VNDA) rating was a reiterated with a price target of $18.00 to $18.00. The current price Vanda Pharma (VNDA) is trading at is $4.83, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch